Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.fdcindia.com | |
Market Cap | 6,452.98 Cr. | |
Enterprise Value(EV) | 6,430.13 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 15.43 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 25.69 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 121.15 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.27 | Calculated using Price: 396.35 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 16.28 Cr. | 162,810,084 Shares |
FaceValue | 1 | |
About FDC Ltd. | ||
FDC Limited is among India's leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world's foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio. |
1 Day |
|
+0.70% |
1 Week |
|
-2.91% |
1 Month |
|
+8.48% |
3 Month |
|
+2.34% |
6 Month |
|
+32.02% |
1 Year |
|
+38.78% |
2 Year |
|
+38.88% |
5 Year |
|
+108.43% |
10 Year |
|
+270.43% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 16.64 | 16.72 | 16.03 | 13.63 | 12.48 | 16.03 | 18.36 | 11.71 | 9.84 | |
Return on Capital Employed (%) | 23.02 | 23.11 | 21.51 | 19.00 | 17.49 | 21.56 | 23.74 | 15.78 | 13.25 | |
Return on Assets (%) | 13.34 | 13.97 | 12.00 | 9.03 | 8.20 | 10.43 | 11.85 | 7.59 | 6.23 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 936 | 1,082 | 1,270 | 1,276 | 1,445 | 1,547 | 1,734 | 1,957 | 1,982 | 1,973 | |
Non Curr. Liab. | 24 | 20 | 217 | 211 | 229 | 315 | 300 | 391 | 469 | 49 | |
Curr. Liab. | 188 | 163 | 389 | 480 | 497 | 565 | 622 | 690 | 730 | 321 | |
Minority Int. | 0 | 0 | -1 | -1 | |||||||
Equity & Liab. | 1,148 | 1,266 | 1,876 | 1,968 | 2,172 | 2,427 | 2,655 | 3,038 | 3,180 | 2,342 | |
Non Curr. Assets | 646 | 742 | 958 | 977 | 1,113 | 1,181 | 1,303 | 1,620 | 1,735 | 1,366 | |
Curr. Assets | 502 | 523 | 918 | 991 | 1,058 | 1,245 | 1,348 | 1,418 | 1,443 | 976 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,148 | 1,266 | 1,876 | 1,968 | 2,172 | 2,427 | 2,655 | 3,038 | 3,180 | 2,342 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 889 | 994 | 1,014 | 1,075 | 1,091 | 1,344 | 1,333 | 1,528 | 1,784 | 1,867 | |
Other Income | 46 | 39 | 50 | 51 | 43 | 69 | 97 | 76 | 51 | 82 | |
Total Income | 935 | 1,033 | 1,064 | 1,126 | 1,134 | 1,413 | 1,430 | 1,604 | 1,835 | 1,949 | |
Total Expenditure | -691 | -766 | -770 | -848 | -860 | -1,051 | -999 | -1,274 | -1,534 | -1,570 | |
PBIDT | 244 | 268 | 294 | 278 | 274 | 362 | 431 | 330 | 301 | 379 | |
Interest | -2 | -1 | -1 | -1 | -1 | -3 | -3 | -3 | -4 | -4 | |
Depreciation | -39 | -34 | -35 | -35 | -33 | -37 | -38 | -37 | -39 | -39 | |
Taxation | -56 | -63 | -63 | -67 | -67 | -80 | -87 | -73 | -64 | -84 | |
Exceptional Items | -6 | -1 | -2 | ||||||||
PAT | 148 | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 194 | 251 | |
Minority Interest | 0 | 0 | 0 | 0 | |||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 148 | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 194 | 251 | |
Adjusted EPS | 8 | 9 | 11 | 10 | 10 | 14 | 18 | 13 | 12 | 15 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 150 | 128 | 174 | 154 | 150 | 112 | 250 | 207 | 162 | 155 | |
Cash Fr. Inv. | -55 | -89 | -73 | -144 | 20 | -120 | -98 | -77 | -145 | 11 | |
Cash Fr. Finan. | -75 | -48 | -97 | 0 | -169 | 0 | -142 | -129 | -10 | -180 | |
Net Change | 19 | -9 | 4 | 11 | 1 | -8 | 10 | 1 | 7 | -14 | |
Cash & Cash Eqvt | 23 | 15 | 16 | 27 | 28 | 20 | 30 | 30 | 38 | 24 |
Tue, 21 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of Earnings Conference Call held on November 16 2023. |
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation |
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio Recordings of Earnings Conference Call held on November 16 2023. |
Fri, 01 Dec 2023 |
|
|
|
|
|